Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 11 931-942, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans

RM Bostick, L Fosdick, TJ Lillemoe, P Overn, JR Wood, P Grambsch, P Elmer and JD Potter
Department of Public Health Sciences, Epidemiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA.

The methodological issues for measuring colorectal epithelial cell proliferation, an intermediate end point for studies of colon neoplasia, in epidemiological studies are deceptively numerous and complex, with few methodological data available. Accordingly, during our experience with measuring colorectal epithelial cell proliferation from nearly 500 participants attending over 1300 study visits over a 6-year period, we recorded data on a variety of measurement variations. Methods investigated included rectal biopsy technique, general histological and labeling procedures [including the tritiated thymidine, 5-bromodeoxyuridine (BrdUrd), and the proliferating cell nuclear antigen (PCNA) immunohistochemical techniques used to label S-phase cells in colonic crypts in rectal biopsy specimens], biopsy scoring procedures, and summary scoring methods. Findings include that the PCNA technique was the simplest, most economical, and least time-consuming. The BrdUrd labeling failure rate was 15% versus < 1% for PCNA. The percentage of labeled cells (labeling index) was highest using PCNA in biopsies processed without prior incubation, intermediate using PCNA in biopsies processed with prior incubation as for BrdUrd, and lowest using BrdUrd. The percentage of labeled cells that were in the upper 40% of the crypt (phi h) was higher using BrdUrd than PCNA; visit-to-visit correlations were higher using PCNA (r = 0.51 versus 0.35), and visit-to-visit variability was lower and between-person variability was higher using PCNA. Intra- and inter-rater reliabilities for the techniques were comparable (PCNA intra-rater r = 0.93, inter-rater r = 0.92). The PCNA technique, compared to the BrdUrd technique, is more feasible and reliable, provides a more accurate estimate of the labeling index, and cell proliferation measures determined with PCNA have statistical properties that are generally more favorable for detecting differences in clinical trials. Thus, the PCNA technique may be preferable to techniques requiring incubation of biopsies. Other methodological findings lead us to recommend that, for larger studies measuring colorectal epithelial cell proliferation on outpatient rectal biopsies, biopsies should be taken 10 cm above the anus using a flexible, preferably jumbo cup, endoscopic forceps through a rigid sigmoidoscope, and histological sections should be 3 microns thick taken 50 microns apart.

This article has been cited by other articles:

				A. Sainsbury, R. A. Goodlad, S. L. Perry, S. G. Pollard, G. G. Robins, and M. A. Hull Increased Colorectal Epithelial Cell Proliferation and Crypt Fission Associated with Obesity and Roux-en-Y Gastric Bypass Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1401 - 1410. [Abstract] [Full Text] [PDF]

				Z. Liu, S.-W. Choi, J. W. Crott, M. K. Keyes, H. Jang, D. E. Smith, M. Kim, P. W. Laird, R. Bronson, and J. B. Mason Mild Depletion of Dietary Folate Combined with Other B Vitamins Alters Multiple Components of the Wnt Pathway in Mouse Colon J. Nutr., December 1, 2007; 137(12): 2701 - 2708. [Abstract] [Full Text] [PDF]

				A. McTiernan, Y. Yasui, B. Sorensen, M. L. Irwin, A. Morgan, R. E. Rudolph, C. Surawicz, J. W. Lampe, K. Ayub, J. D. Potter, et al. Effect of a 12-month exercise intervention on patterns of cellular proliferation in colonic crypts: a randomized controlled trial. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1588 - 1597. [Abstract] [Full Text] [PDF]

				K. F Adams, P. D Lampe, K. M Newton, J T. Ylvisaker, A. Feld, D. Myerson, S. S Emerson, E. White, J. D Potter, and J. W Lampe Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial Am. J. Clinical Nutrition, September 1, 2005; 82(3): 620 - 626. [Abstract] [Full Text] [PDF]

				R. C. Lewis, R. M. Bostick, D. Xie, Z. Deng, M. J. Wargovich, M. F. Fina, W. M. Roufail, and K. R. Geisinger Polymorphism of the Cyclin D1 Gene, CCND1, and Risk for Incident Sporadic Colorectal Adenomas Cancer Res., December 1, 2003; 63(23): 8549 - 8553. [Abstract] [Full Text] [PDF]

				R. S. Sandler, J. A. Baron, T. D. Tosteson, J. S. Mandel, and R. W. Haile Rectal Mucosal Proliferation and Risk of Colorectal Adenomas: Results from a Randomized Controlled Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 653 - 656. [Abstract] [Full Text]

				B. A. Magnuson, M. Davis, S. Hubele, P. R. Austin, I. T. Kudva, C. J. Williams, C. W. Hunt, and C. J. Hovde Ruminant Gastrointestinal Cell Proliferation and Clearance of Escherichia coli O157:H7 Infect. Immun., July 1, 2000; 68(7): 3808 - 3814. [Abstract] [Full Text] [PDF]

				P. R. Holt Dairy Foods and Prevention of Colon Cancer: Human Studies J. Am. Coll. Nutr., October 1, 1999; 18(90005): 379S - 391. [Abstract] [Full Text] [PDF]

				D. J. Ahnen and T. Byers Proliferation Happens JAMA, September 23, 1998; 280(12): 1095 - 1096. [Full Text] [PDF]